Status: current, Defined. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3739481017 | Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3739482012 | Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3739483019 | Dehydrocholic acid and pancreatin and simethicone only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Is a | Dehydrocholic acid and pancreatin and simeticone only product | true | Inferred relationship | Some | ||
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Is a | Dehydrocholic acid- and pancreatin- and simethicone-containing product in oral dose form | true | Inferred relationship | Some | ||
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Has active ingredient | Simeticone | true | Inferred relationship | Some | 3 | |
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Has active ingredient | Pancreatin | true | Inferred relationship | Some | 1 | |
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Has active ingredient | Dehydrocholic acid | true | Inferred relationship | Some | 2 | |
Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Plays role | Digestant therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet | Is a | True | Dehydrocholic acid and pancreatin and simeticone only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets